News | August 11, 2024
Merck inks MoU with Aragen to facilitate supply of equipment and technologies for mAb
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
PEKK is a high-performance polymer family used in aerospace and other demanding markets
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Accelerating sustainability in Indian pharma industry
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Subscribe To Our Newsletter & Stay Updated
